InvestSMART

Imagion Biosystems Limited (ASX: IBX) - Announcements

- Current share price for IBX : $0.005

ASX company news and announcements for Imagion Biosystems Limited (IBX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imagion Biosystems Limited (IBX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imagion Biosystems Limited (IBX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imagion Biosystems Limited (IBX)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$4 Update - Proposed issue of securities - IBX 25 Jun 2026 2:18PM $0.012 $0.005 fallen by 58.33%
$4 Proposed issue of securities - IBX 25 Jun 2026 9:29AM $0.015 $0.005 fallen by 66.67%
$4 Proposed issue of securities - IBX 25 Jun 2026 9:29AM $0.015 $0.005 fallen by 66.67%
$4 Proposed issue of securities - IBX 25 Jun 2026 9:29AM $0.015 $0.005 fallen by 66.67%
$4 IBX Secures Firm Commitments for $3.75m for Clinical Trial 25 Jun 2026 9:28AM $0.015 $0.005 fallen by 66.67%
$4 Trading Halt 23 Jun 2026 9:33AM $0.015 $0.005 fallen by 66.67%
$4 Notification of cessation of securities - IBX 12 Jun 2026 3:31PM $0.016 $0.005 fallen by 68.75%
$4 Imagion Biosystems Receives IND Clearance from US FDA 2 Jun 2026 9:05AM $0.017 $0.005 fallen by 70.59%
$4 Notification of cessation of securities - IBX 28 May 2026 3:00PM $0.015 $0.005 fallen by 66.67%
$4 Results of Annual General Meeting 26 May 2026 3:21PM $0.013 $0.005 fallen by 61.54%
$4 Investor Presentation 26 May 2026 9:45AM $0.013 $0.005 fallen by 61.54%
$4 IBX Chairman's AGM Address 26 May 2026 9:42AM $0.013 $0.005 fallen by 61.54%
$4 Change of Director's Interest Notice - Robert Proulx 8 May 2026 12:06PM $0.016 $0.005 fallen by 68.75%
$4 Notification of cessation of securities - IBX 4 May 2026 12:11PM $0.016 $0.005 fallen by 68.75%
$4 Notice of Annual General Meeting/Proxy Form 24 Apr 2026 11:16AM $0.019 $0.005 fallen by 73.68%
$4 Notification regarding unquoted securities - IBX 23 Apr 2026 2:39PM $0.021 $0.005 fallen by 75.61%
$4 Cleansing Statement - Section 708A(12C)(e) 23 Apr 2026 2:14PM $0.021 $0.005 fallen by 75.61%
$4 Appendix 4C and Quarterly Activities Report - March 2026 23 Apr 2026 12:16PM $0.022 $0.005 fallen by 77.27%
$4 Proposed issue of securities - IBX 16 Apr 2026 4:29PM $0.022 $0.005 fallen by 77.27%
$4 IBX Update Regarding Short Term Funding Facilities 8 Apr 2026 10:50AM $0.022 $0.005 fallen by 77.27%
$4 Date of AGM and Closing Date for Director Nominations 7 Apr 2026 3:08PM $0.021 $0.005 fallen by 76.19%
$4 Notification of cessation of securities - IBX 2 Apr 2026 4:09PM $0.021 $0.005 fallen by 76.19%
$4 Appendix 3H Lodged Late - Part Repayment of Convertible Note 2 Apr 2026 3:16PM $0.022 $0.005 fallen by 77.27%
$4 Notification of cessation of securities - IBX 2 Apr 2026 3:14PM $0.022 $0.005 fallen by 77.27%
$4 Appendix 4G and Corporate Governance Statement 27 Feb 2026 2:57PM $0.028 $0.005 fallen by 81.82%

26 - 50 of 693 results

Page 2 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.